Description of the blood test:

Mitochondria are the “power plants” of our cells, responsible for energy production. Antimitochondrial antibodies (AMA) are autoantibodies that target a protein complex found on the inner membrane of these mitochondria. The presence of AMA is highly specific to Primary Biliary Cholangitis (PBC)—formerly known as Primary Biliary Cirrhosis. In this condition, the immune system attacks and destroys the small bile ducts within the liver, leading to bile buildup, liver scarring, and eventually liver failure.

What Does the Test Represent?

• Goal: To detect the presence of antibodies (specifically the M2 subtype) against mitochondrial antigens.
• Main Application: Diagnosing Primary Biliary Cholangitis and investigating unexplained cholestasis (bile flow blockage).
• Method: Indirect Immunofluorescence (IIF) or Enzyme-Linked Immunosorbent Assay (ELISA).

Collection Recommendations (General)

• Timing: Morning collection is preferred.
• Fasting: Fasting for 8–12 hours is recommended; plain water is allowed.
• Material: Venous blood (serum).
• Specific Rules: Inform your doctor about any symptoms of itching or fatigue, as these are the hallmark early signs of the disease associated with this marker.

Factors Influencing the Result

• Specificity: AMA is one of the most accurate tests in rheumatology/hepatology; about 95% of people with PBC will test positive.
• Healthy Population: It is very rare to find AMA in healthy individuals (less than 1%).
• Other Conditions: Low levels can occasionally be found in other autoimmune diseases like Systemic Sclerosis or Sjögren’s Syndrome, but usually, it points directly to the liver.

When to Take This Test?

• Recommendations: If you have unexplained, persistent itching (pruritus), chronic fatigue, or if blood tests show elevated liver enzymes (especially Alkaline Phosphatase/ALP and GGT).
• Importance: Early detection of PBC via the AMA test allows doctors to start treatment with ursodeoxycholic acid (UDCA), which can significantly slow down liver damage and prevent the need for a transplant.

Medical Interpretation

• Crucial Note: A positive AMA result is highly significant. Even if liver enzymes are currently normal, a positive AMA often predicts that PBC will develop in the future. Only a specialist can “fine-tune” the diagnosis by correlating the antibody level with a liver ultrasound or biopsy.
• Positive Result: Strongly suggests Primary Biliary Cholangitis.
• Negative Result: Makes PBC unlikely, although about 5% of patients have “AMA-negative” PBC.

Possible Further Investigations

• Alkaline Phosphatase (ALP) and GGT: These enzymes are almost always elevated in patients with positive AMA.
• Anti-Smooth Muscle Antibodies (ASMA) and ANA: To rule out other types of autoimmune hepatitis.
• Liver Ultrasound or MRCP: To visualize the bile ducts and check for other causes of blockage (like gallstones).
• Liver Biopsy: To determine the stage of the disease and the degree of scarring.
• Consultation with a Hepatologist.

When Does the Next Step Make Sense?

• If the AMA test is positive, the next step is a detailed evaluation by a hepatologist. Because PBC is a progressive disease, starting treatment early is the most effective way to protect liver function. Regular monitoring of liver enzymes will follow to ensure the therapy is working.
• All clinical decisions must be made by a healthcare professional based on the combination of lab markers and liver imaging.

👉 If necessary, you can discuss the analysis results with a specialist such as a gastroenterologist (Doctors – TAMC).